Crovalimab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria.
Journal: Expert review of clinical pharmacology
Published: May 29, 2026
Efficacy and Safety of Treatments for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review.
Journal: Journal of clinical medicine
Published: March 26, 2026
Improvement in anemia and symptoms after switching from crovalimab to iptacopan in paroxysmal nocturnal hemoglobinuria.
Journal: Hematology (Amsterdam, Netherlands)
Published: January 29, 2026
Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 12, 2026
Crovalimab Rescue Therapy in a Case With Genetic Complement Mediated Thrombotic Microangiopathy.
Journal: Kidney medicine
Published: January 08, 2026
Exploring individualized crovalimab dosing in PNH through in silico modelling: Potential for improved convenience and cost efficiency.
Journal: British journal of clinical pharmacology
Published: December 22, 2025
Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.
Journal: Cells
Published: December 02, 2025
New Anticomplement Drugs in Nephrology: Mechanism and Indication.
Journal: Kidney & blood pressure research
Published: November 28, 2025
Donor-Derived Cell-Free DNA (dd-cfDNA) as an Early Noninvasive Biomarker of Graft Injury in Pig-to-Monkey Islet Xenotransplantation.
Journal: Xenotransplantation
Published: November 11, 2025
Paroxysmal Nocturnal Hemoglobinuria in Patients with Systemic Lupus Erythematosus: Diagnostic Challenges and Improvement with C5 Inhibitor Treatment.
Journal: Internal medicine (Tokyo, Japan)
Published: October 22, 2025
Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling.
Journal: Expert opinion on biological therapy
Published: October 13, 2025
Last Updated: 06/30/2026